FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Should Move More Drugs OTC: Opinion

Singer further suggests that Congress could explore forms of international drug reciprocity, allowing Americans to purchase certain drugs over the cou...

latest-news-card-1
Human Drugs

Common Violations in Recent DTC Letters from FDA

A law firm examines FDAs renewed scrutiny of direct-to-consumer television advertising after issuing seven untitled letters so far in 2026.

latest-news-card-1
Medical Devices

Medline Class 1 Recall on Malfunctioning Beds

Medline recalls (Class 1 device correction) certain Medline homecare beds as a Class I recall, warning that continued use without updated instructions...

latest-news-card-1
Medical Devices

FDA Shifts to Risk-Based Device Inspections under QMSR

As part of FDAs recent implementation of the Quality Management System Regulation, a new risk-based inspection model is set to change medical device o...

latest-news-card-1
Human Drugs

PTC Yanks Translarna NDA After FDA Signals Data Shortfall

PTC Therapeutics withdraws its NDA resubmission for Translarna (ataluren) to treat nonsense mutation Duchenne muscular dystrophy, following feedback f...

latest-news-card-1
Human Drugs

Researchers Urge FDA Caution in Phasing Out Animal Testing

A new academic paper urges FDA to proceed cautiously as it moves to phase out animal testing in drug development, warning that moving too fast to tran...

latest-news-card-1
Human Drugs

FDA Faces High Hurdle to Expand DTC Ad Disclosures: WLF

A 2/11 Washington Legal Foundation legal backgrounder argues that FDA would face steep statutory hurdles if it attempts to dramatically expand disclos...

latest-news-card-1
Human Drugs

FDA OKs Pulling Boxed Warnings from 6 HRT Drugs

FDA approves labeling changes removing some Boxed Warnings from six hormone replacement therapy products.

latest-news-card-1
Human Drugs

Legal Scholars Warn Infringement by Label Will Harm Generics

A new article in the New England Journal of Medicine warns that recent federal court rulings are transforming FDA-required drug labels into powerful w...

Biologics

Turmoil Mounts Under Prasads Leadership: WSJ

CBER faces mounting scrutiny after its top official, director Vinay Prasad, refused the review of Modernas flu vaccine application a move that some sa...